Pediatric Glue-Related Injuries in U.S. Emergency Departments: A 10-Year Overview

Albert L Zhang1, Jeffrey P Louie2, Henry W Ortega3

  • 1Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

Clinical Pediatrics
|July 8, 2022
PubMed

Insights

Pediatric glue injuries are rising, with eyes most commonly affected by splashes. Younger children may ingest glue, while older children risk burns, highlighting the need for better prevention.

Area of Science:

  • Pediatric Emergency Medicine
  • Toxicology
  • Consumer Product Safety

Background:

  • Slime's popularity increases children's exposure to glue.
  • Limited literature exists on pediatric glue-related injuries.
  • Emergency department (ED) data can characterize these injuries.

Purpose of the Study:

  • To characterize pediatric glue-related injuries treated in U.S. EDs.
  • To analyze injury trends and mechanisms.
  • To identify age-related differences in injury types.

Main Methods:

  • Utilized the National Electronic Injury Surveillance System (NEISS) for data from 2009-2018.
  • Abstracted data from discrete and narrative fields.
  • Calculated odds ratios to assess age-related injury variations.

Main Results:

  • An estimated 18,126 pediatric patients received ED treatment for glue injuries.
  • Injury incidence showed an increasing trend over the study period.
  • The eye was the most frequently injured body part, often due to unintentional splashes; foreign body was the most common diagnosis.
  • Younger children had higher rates of glue ingestion, whereas older children sustained more burns.

Conclusions:

  • Pediatric glue-related injuries are a growing concern, particularly eye injuries from splashes.
  • Age-specific risks (ingestion in younger, burns in older children) necessitate tailored prevention.
  • Preventive strategies should include enhanced supervision, proper storage, and personal protective equipment.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...